0001596771-19-000084.txt : 20190726
0001596771-19-000084.hdr.sgml : 20190726
20190726163059
ACCESSION NUMBER: 0001596771-19-000084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190724
FILED AS OF DATE: 20190726
DATE AS OF CHANGE: 20190726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LICHTINGER PEDRO
CENTRAL INDEX KEY: 0001470741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 19978351
MAIL ADDRESS:
STREET 1: 1301 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemphire Therapeutics Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
BUSINESS PHONE: 248-980-6538
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-07-24
0
0001638287
Gemphire Therapeutics Inc.
GEMP
0001470741
LICHTINGER PEDRO
17199 N. LAUREL PARK DRIVE
SUITE 401
LIVONIA
MI
48152
1
0
0
0
Common Stock
2019-07-24
4
A
0
15000
0
A
74833
D
/s/ Stephanie Swan, by Power of Attorney
2019-07-26